Erja Chryssanthou

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: MYCOSES. 2022;65(1):79-87
Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?
Kurland S; Lowdin E; Furebring M; Shams A; Chryssanthou E; Lagerback P; Tangden T; Breuer O; Sjolin J
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2021;65(12):e0149521-10.1128/aac.01421
Antifungal Susceptibility of 182 Fusarium Species Isolates from 20 European Centers: Comparison between EUCAST and Gradient Concentration Strip Methods
Blaize M; Normand A-C; Imbert S; Al-Hatmi AMS; Chryssanthou E; Cassaing S; Schuttler C; Hasseine L; Mahinc C; Costa D; Bonnal C; Ranque S; Sautour M; Rubio E; Delhaes L; Riat A; Sendid B; Kristensen L; Brandenberger M; Stubbe D; Brun S; Piarroux R; Fekkar A
Article: JOURNAL OF FUNGI. 2021;7(4):246
Clinical Origin and Species Distribution of Fusarium spp. Isolates Identified by Molecular Sequencing and Mass Spectrometry: A European Multicenter Hospital Prospective Study
Normand A-C; Imbert S; Brun S; Al-Hatmi AMS; Chryssanthou E; Cassaing S; Schuttler C; Hasseine L; Mahinc C; Costa D; Bonnal C; Ranque S; Sautour M; Rubio E; Delhaes L; Riat A; Sendid B; Kristensen L; Brandenberger M; Guitard J; Packeu A; Piarroux R; Fekkar A
Article: LAKARTIDNINGEN. 2020;117:20039
[Is it time to use sputum induction as a complementary specimen collection procedure in adult patients with suspected pulmonary tuberculosis?].
Kuhlin J; Tammelin A; Petersson J; Chryssanthou E; Tideholm-Nylén A; Schön T; Bruchfeld J
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2020;75(7):1807-1819
Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes
Arendrup MC; Jorgensen KM; Guinea J; Lagrou K; Chryssanthou E; Hayette M-P; Barchiesi F; Lass-Floerl C; Hamal P; Dannaoui E; Chowdhary A; Meletiadis J
Article: TUBERCULOSIS. 2020;123:101959
CD4⁺ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection
Borgstrom EW; Froberg G; Correia-Neves M; Atterfelt FB; Bellbrant J; Szulkin R; Chryssanthou E; Angeby K; Tecleab T; Ruhwald M; Andersen P; Kallenius G; Bruchfeld J
Article: GENOME MEDICINE. 2020;12(1):27
Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex
Merker M; Kohl TA; Barilar I; Andres S; Fowler PW; Chryssanthou E; Angeby K; Jureen P; Moradigaravand D; Parkhill J; Peacock SJ; Schon T; Maurer FP; Walker T; Koser C; Niemann S
Article: MYCOSES. 2019;62(11):1043-1048
Estimated burden of fungal infections in Sweden
Ozenci V; Klingspor L; Ullberg M; Chryssanthou E; Denning DW; Kondori N
Article: ERJ OPEN RESEARCH. 2019;5(2):78-2019
A new mathematical model to identify contacts with recent and remote latent tuberculosis
Froberg G; Borgstrom EW; Chryssanthou E; Correia-Neves M; Kallenius G; Bruchfeld J
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2019;63(1):e01651-e01618
Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods
Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Botterel F; Canton E; Castro C; Chen Y-C; Chen Y; Chryssanthou E; Dannaoui E; Garcia-Effron G; Gonzalez GM; Govender NP; Guinea J; Kidd S; Lackner M; Lass-Floerl C; Linares-Sicilia MJ; Lopez-Soria L; Magobo R; Pelaez T; Quindos G; Rodriguez-Iglesia MA; Ruiz MA; Sanchez-Reus F; Sanguinetti M; Shields R; Szweda P; Tortorano A; Wengenack NL; Bramati S; Cavanna C; DeLuca C; Gelmi M; Grancini A; Lombardi G; Meletiadis J; Negri CE; Passera M; Peman J; Prigitano A; Sala E; Tejada M
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(10):2838-2845
Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting
Niward K; Forsman LD; Bruchfeld J; Chryssanthou E; Carlstrom O; Alomari T; Carlsson B; Pohanka A; Mansjo M; Nordvall MJ; Johansson AG; Eliasson E; Werngren J; Paues J; Simonsson USH; Schon T
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2018;62(5):e00218
Plasma Levels of Rifampin Correlate with the Tuberculosis Drug Activity Assay
Niward K; Blom LE; Forsman LD; Bruchfeld J; Eliasson E; Schon T; Chryssanthou E; Paues J
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2018;62(4):e01916-e01917
Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values
Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Dannaoui E; Garcia-Effron G; Guinea J; Kidd S; Pelaez T; Sanguinetti M; Meletiadis J; Botterel F; Bustamante B; Chen Y-C; Chakrabarti A; Chowdhary A; Chryssanthou E; Cordoba S; Gonzalez GM; Guarro J; Johnson EM; Kus JV; Lass-Floerl C; Linares-Sicilia MJ; Martin-Mazuelos E; Negri CE; Pfaller MA; Tortorano AM
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2017;55:122-124
Minimum inhibitory concentration distributions for Mycobacterium avium complex-towards evidence-based susceptibility breakpoints
Schon T; Chryssanthou E
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(2):333-338
Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB
Niward K; Angeby K; Chryssanthou E; Paues J; Bruchfeld J; Jureen P; Giske CG; Kahlmeter G; Schon T
Article: EMERGING INFECTIOUS DISEASES. 2015;21(6):1041-1044
Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus
van der Linden JWM; Arendrup MC; Warris A; Lagrou K; Pelloux H; Hauser PM; Chryssanthou E; Mellado E; Kidd SE; Tortorano AM; Dannaoui E; Gaustad P; Baddley JW; Uekoetter A; Lass-Floerl C; Klimko N; Moore CB; Denning DW; Pasqualotto AC; Kibbler C; Arikan-Akdagli S; Andes D; Meletiadis J; Naumiuk L; Nucci M; Melchers WJG; Verweij PE
Article: FUNGAL BIOLOGY AND BIOTECHNOLOGY. 2015;2:1
Penicillium nalgiovense Laxa isolated from Antarctica is a new source of the antifungal metabolite amphotericin B.
Svahn KS; Chryssanthou E; Olsen B; Bohlin L; Göransson U
Article: MYCOSES. 2014;57(10):630-638
The effect of K101 Nail Solution on Trichophyton rubrum and Candida albicans growth and ultrastructure
Hultenby K; Chryssanthou E; Klingspor L; Rensfeldt K; Strombeck L; Faergemann J
Article: PLOS ONE. 2014;9(4):e93685
Induction of Gliotoxin Secretion in Aspergillus fumigatus by Bacteria-Associated Molecules
Svahn KS; Goransson U; Chryssanthou E; Olsen B; Sjolin J; Stromstedt AA
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2013;57(12):5836-5842
Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?
Espinel-Ingroff A; Arendrup MC; Pfaller MA; Bonfietti LX; Bustamante B; Canton E; Chryssanthou E; Cuenca-Estrella M; Dannaoui E; Fothergill A; Fuller J; Gaustad P; Gonzalez GM; Guarro J; Lass-Floerl C; Lockhart SR; Meis JF; Moore CB; Ostrosky-Zeichner L; Pelaez T; Pukinskas SRBS; St-Germain G; Szeszs MW; Turnidge J
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2013;68(9):2074-2077
Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
Schon T; Jureen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
Article: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2013;2(2):103-108
Epidemiological analyses of tuberculosis in Archangelsk, Russia and implementation of a rapid assay for detection of resistance in this high burden setting.
Eliseev PI; Maryandyshev AO; Nikishova EI; Tarasova IV; Gorina GP; Chryssanthou E; Ridell M; Larsson L-O
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2013;19(4):E218-E221
Candidaemia in Sweden: a nationwide prospective observational survey
Ericsson J; Chryssanthou E; Klingspor L; Johansson AG; Ljungman P; Svensson E; Sjolin J
Article: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2012;1(4):177-179
Tentative susceptibility testing breakpoint for the neuroleptic drug thioridazine, a treatment option for multi- and extensively drug resistant tuberculosis.
Ängeby K; Juréen P; Chryssanthou E; Schön T
Article: APMIS. 2012;120(5):405-409
The GenoType® MTBDRplus assay for detection of drug resistance in Mycobacterium tuberculosis in Sweden
Chryssanthou E; Angeby K
Article: INFECTION ECOLOGY & EPIDEMIOLOGY. 2012;2:11591
Antimicrobial activity of filamentous fungi isolated from highly antibiotic-contaminated river sediment.
Svahn KS; Göransson U; El-Seedi H; Bohlin L; Larsson DGJ; Olsen B; Chryssanthou E
Article: MYCOSES. 2011;54(6):e811-e815
Occurrence of yeasts in faecal samples from Antarctic and South American seabirds
Chryssanthou E; Wennberg H; Bonnedahl J; Olsen B
Article: MEDICAL MYCOLOGY. 2011;49(5):484-488
Epidemiology of dermatophyte infections in Stockholm, Sweden: a retrospective study from 2005-2009
Drakensjo IT; Chryssanthou E
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2011;55(7):3099-3104
Posaconazole in Human Serum: a Greater Pharmacodynamic Effect than Predicted by the Non-Protein-Bound Serum Concentration
Lignell A; Lowdin E; Cars O; Chryssanthou E; Sjolin J
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2011;15(4):502-509
Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis
Schon T; Jureen P; Chryssanthou E; Giske CG; Sturegard E; Kahlmeter G; Hoffner S; Angeby KA
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2010;65(5):946-952
Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data
Angeby KA; Jureen P; Giske CG; Chryssanthou E; Sturegard E; Nordvall M; Johansson AG; Werngren J; Kahlmeter G; Hoffner SE; Schon T
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2010;48(5):1853-1858
Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections
Jureen P; Angeby K; Sturegard E; Chryssanthou E; Giske CG; Werngren J; Nordvall M; Johansson A; Kahlmeter G; Hoffner S; Schon T
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009;64(4):786-793
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis
Schon T; Jureen P; Giske CG; Chryssanthou E; Sturegard E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
Article: APMIS. 2009;117(4):286-290
Drug resistance and genotypic analysis of Mycobacterium tuberculosis strains from Thai tuberculosis patients
Cheunoy W; Haile M; Chaiprasert A; Prammananan T; Cristea-Fernstrom M; Vondracek M; Chryssanthou E; Hoffner S; Petrini B
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2008;61(6):1309-1311
Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia
Chryssanthou E; Loebig A; Sjolin J
Article: MEDICAL MYCOLOGY. 2008;46(1):57-65
Histoplasmosis in europe: Report on an epidemiological survey from the european confederation of medical mycology working group
Ashbee HR; Evans EGV; Viviani MA; Dupont B; Chryssanthou E; Surmont I; Tomsikova A; Vachkov P; Enero B; Zala J; Tintelnot K
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2008;12(2):199-204
Extensive transmission of an isoniazid-resistant strain of Mycobacterium tuberculosis in Sweden
Kan B; Berggren I; Ghebremichael S; Bennet R; Bruchfeld J; Chryssanthou E; Kallenius G; Petersson R; Petrini B; Romanus V; Sylvan S; Kalin M
Article: APMIS. 2007;115(11):1281-1284
Performance of commercial latex agglutination tests for the differentiation of Candida dubliniensis and Candida albicans in routine diagnostics
Chryssanthou E; Fernandez V; Petrini B
Article: APMIS. 2007;115(11):1252-1259
Pyrosequencing of a short hypervariable 16S rDNA fragment for the identification of nontuberculous mycobacteria -: a comparison with conventional 16S rDNA sequencing and phenotyping
Cristea-Fernstrom M; Olofsson M; Chryssanthou E; Jonasson J; Petrini B
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2007;13(10):1018-1022
Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)
Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL
Article: EYE. 2007;21(7):968-975
Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis
Nivenius E; van der Ploeg I; Jung K; Chryssanthou E; van Hage M; Montan PG
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2007;45(1):109-111
Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2).
Rodriguez-Tudela JL; Donnelly JP; Pfaller MA; Chryssantou E; Warn P; Denning DW; Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2007;39(4):337-343
Diagnostics of fungal infections in the Nordic countries: We still need to improve!
Arendrup MC; Chryssanthou E; Gaustad P; Koskela M; Sandven P; Fernandez V
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2006;12(9):901-904
Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.
Chryssanthou E; Cuenca-Estrella M
Article: MYCOPATHOLOGIA. 2006;161(3):167-172
Clinico-mycological profile of dermatophytosis in a reference centre for leprosy and dermatological diseases in Addis Ababa
Woldeamanuel Y; Leekassa R; Chryssanthou E; Mengistu Y; Petrini B
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2006;38(1):76-78
A fatal case of severe immunodeficiency associated with disseminated Merulius tremellosus infection
Friman V; Gisslén M; Nikkari S; Stenlid J; Chryssanthou E; Petrini BR
Article: APMIS. 2005;113(10):708-712
White variants of Trichophyton violaceum isolated in Ethiopia
Woldeamanuel Y; Leekassa R; Petrini B; Chryssanthou E
Article: MYCOSES. 2005;48(2):137-141
Prevalence of tinea capitis in Ethiopian schoolchildren
Woldeamanuel Y; Leekassa R; Chryssanthou E; Menghistu Y; Petrini B
Article: MEDICAL MYCOLOGY. 2005;43(1):79-82
Dermatophytosis in Tulugudu Island, Ethiopia
Woldeamanuel Y; Mengistu Y; Chryssanthou E; Petrini B
Article: ETHIOPIAN MEDICAL JOURNAL. 2005;43(1):31-34
In vitro activity of Phytolacca dodecandra (Endod) against dermatophytes
Woldeamanuel Y; Abate G; Chryssanthou E
Article: MICROBES AND INFECTION. 2004;6(14):1320-1325
Genetic diversity in clinical isolates of Mycobacterium avium complex from Guinea-Bissau, West Africa
Koivula T; Cristea-Fernström M; Chryssanthou E; Petrini B; Källenius G
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2004;54(5):940-943
Post-antifungal effect of amphotericin B and voriconazole against Aspergillus fumigatus analysed by an automated method based on fungal CO₂ production:: dependence on exposure time and drug concentration
Chryssanthou E; Sjölin J
Article: CLINICAL AND EXPERIMENTAL ALLERGY. 2004;34(5):725-730
No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic keratoconjunctivitis
Nivenius E; Montan PG; Chryssanthou E; Jung K; van Hage-Hamsten M; van der Ploeg I
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2004;36(11-12):855-859
Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies
Chryssanthou E; Cherif H; Petrini B; Kalin M; Björkholm M
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2003;41(11):5236-5237
Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi
Rodriguez-Tudela JL; Chryssanthou E; Petrikkou E; Mosquera J; Denning DW; Cuenca-Estrella M
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2003;9(8):i-viii
Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts
Rodríguez-Tudela JL; Barchiesi F; Bille J; Chryssanthou E; Cuenca-Estrella M; Denning D; Donnelly JP; Dupont B; Fegeler W; Moore C; Richardson M; Verweif PE
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2002;46(12):4016-4018
New automated method for determining postantifungal effect of amphotericin B against Candida species:: Effects of concentration, exposure time, and area under the curve
Chryssanthou E; Cars O; Sjölin J
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2002;40(10):3841-3844
Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species
Chryssanthou E; Cuenca-Estrella M
Article: LAKARTIDNINGEN. 2002;99(20):2293-2294
[Antifungal agents can change the balance between resistant and susceptible Candida species].
Petrini B; Chryssanthou E
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2001;39(11):4181-4183
Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998:: Comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method
Chryssanthou E
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2001;90(3):323-327
Malassezia pachydermatis fungaemia in a neonatal intensive care unit
Chryssanthou E; Broberger U; Petrini B
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2000;32(4):440-441
Coccidioidomycosis as imported atypical pneumonia in Sweden
Fohlman J; Sjölin J; Bennich H; Chryssanthou E; Von Rosen M; Petrini B
Article: MYCOSES. 1999;42(4):239-247
PCR and other non-culture methods for diagnosis of invasive Candida infections in allogeneic bone marrow and solid organ transplant recipients
Chryssanthou E; Klingspor L; Tollemar J; Petrini B; Larsson L; Christensson B; Ringdén O
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1998;30(5):489-493
Low incidence of candidaemia among neutropenic patients treated for haematological diseases
Chryssanthou E; Kalin M; Engervall P; Petrini B; Björkholm M
Article: MYCOSES. 1997;40(11-12):423-427
Comparison of broth macrodilution, broth microdilution and E-test susceptibility tests of Cryptococcus neoformans for fluconazole
Chryssanthou E; Gronfors C; Khanna N
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1997;29(5):509-512
In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. Acquired resistance to itraconazole
Chryssanthou E
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1997;29(6):635-638
Candida glabrata prosthesis infection following pyelonephritis and septicaemia
Nayeri F; Cameron R; Chryssanthou E; Johansson L; Söderström C
Article: MYCOSES. 1996;39(9-10):353-356
Increased prevalence of oral Candida albicans serotype B in homosexual men: A comparative and longitudinal study in HIV-infected and HIV-negative patients
Torssander J; Chryssanthou E; Petrini B
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1995;27(4):391-395
ORAL CANDIDA-ALBICANS ISOLATES WITH REDUCED SUSCEPTIBILITY TO FLUCONAZOLE IN SWEDISH HIV-INFECTED PATIENTS
CHRYSSANTHOU E; TORSSANDER J; PETRINI B
Visa fler

Alla övriga publikationer

Letter: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022;77(4):1212-1213
Comment on: Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes
Arendrup MC; Jorgensen KM; Guinea J; Lagrou K; Chryssanthou E; Hayette M-P; Barchiesi F; Lass-Floerl C; Hamal P; Dannaoui E; Chowdhary A; Hare RK; Meletiadis J
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2019;25(6):681-687
How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates.
Guinea J; Verweij PE; Meletiadis J; Mouton JW; Barchiesi F; Arendrup MC; Subcommittee on Antifungal Susceptibility Testing
Letter: ACTA DERMATO-VENEREOLOGICA. 2009;89(5):536-537
Combs and Hair-trimming Tools as Reservoirs for Dermatophytes in Juvenile Tinea Capitis
Winge MCG; Chryssanthou E; Wahlgren C-F
Editorial comment: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2003;92(8):980-982
Bone and joint infection after traumatic implantation of Scedosporium prolificans treated with voriconazole and surgery
Studahl M; Backteman T; Stålhammar F; Chryssanthou E; Petrini B
Letter: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2000;32(4):450-451
Mycobacterium shimoidei, an easily misdiagnosed non-tuberculous pulmonary mycobacterium
Sundman K; Chryssanthou E; Petrini B
Thesis / dissertation: 1998
Studies on laboratory diagnosis of fungal infection and antifungal susceptibility
Chryssanthou, Erja
Review: LAKARTIDNINGEN. 1998;95(8):738-742
[Advances in the diagnosis of mycoses. New tests detect Candida infections].
Petrini B; Christensson B; Chryssanthou E; Edebo L; Larsson L
Letter: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1998;30(6):643
Resistance of Aspergillus fumigatus to itraconazole
Chryssanthou E
Other: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1995;27(4):421-424
FLUCONAZOLE FAILURE IN 2 CASES OF DISSEMINATED CANDIDOSIS
JAHNSON L; CHRYSSANTHOU E; PETRINI B; VIKERFORS T

Anställningar

Anknuten till Forskning, Laboratoriemedicin, Karolinska Institutet, 2023-2025

Examina och utbildning

Docent, experimentell mikrobiologi, karolinska institutet, 2011
MEDICINE DOKTORSEXAMEN, INST F LABORATORIEMEDICIN (K5), Karolinska Institutet, 1998

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI